National Academies Press: OpenBook
« Previous: Appendix B: Speaker Biographical Sketches
Suggested Citation:"Appendix C: Registered Attendees." Institute of Medicine. 2011. Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13133.
×

C
Registered Attendees

Kevin Anderson

DHS Science & Technology


George Annas

Boston University


Naomi Aronson

Blue Cross and Blue Shield Technology Evaluation Center


LeeAnn Bailey

Deloitte LLP


Robert Becker

U.S. Food and Drug Administration


Judith Benkendorf

American College of Medical Genetics


Jim Black

TRICARE Management Activity


Bruce Blumberg

Kaiser Permanente


Denise Bonds

National Heart, Lung, and Blood Institute


Khaled Bouri

U.S. Food and Drug Administration


Joel V. Brill

Independent


Amy Brower

American College of Medical Genetics


Jonca Bull

Novartis Pharmaceuticals


Ned Calonge

The Colorado Trust

Suggested Citation:"Appendix C: Registered Attendees." Institute of Medicine. 2011. Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13133.
×

Kathryn Camp

Office of Dietary Supplements National Institutes of Health


Julie Cantor-Weinberg

College of American Pathologists


A. Egon Cholakian

IRDF Project Harvard / Columbia


Melina Cimler

Illumina Inc.


Ralph Coates

Centers for Disease Control and Prevention


Constanze Coon

Deloitte LLP


Marsha Deckman

Peconic Bay Medical Center


Patricia Deverka

Center for Medical Technology Policy


Melinda DiVito

The National Academies


Bernard Edelman

Vietnam Veterans of America


Aled Edwards

Structural Genomics Consortium


Robert Epstein

Medco Health Solutions, Inc.


William Gregory Feero

National Human Genome Research Institute


Amanda Field

Genetic Alliance


Andrew Freedman

National Cancer Institute


Gregory Germino

National Institute of Diabetes and Digestive and Kidney Diseases


Geoffrey Ginsburg

Duke University


Theresa Gorenc

Avalere Health


Linda Griffith

University of Kansas Medical Center


Manjit Hanspal

National Institutes of Health


Daniel Hayes

University of Michigan Comprehensive Cancer Center


Peter Henderson

PWHenderson


Bradford Hirsch

Duke University


India Hook-Barnard

The National Academies


Janet Jenkins-Showalter

Roche


Sharon Kardia

University of Michigan School of Public Health

Suggested Citation:"Appendix C: Registered Attendees." Institute of Medicine. 2011. Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13133.
×

Alice Kau

National Institute of Child Health and Human Development


Alisha Keehn

American College of Medical Genetics


James Kelly

Roche Molecular Systems


Mohamed Khan

American Medical Association


Muin Khoury

Centers for Disease Control and Prevention


Roger Klein

BloodCenter of Wisconsin


Pei Koay

Chemical Heritage Foundation


Hanns Kuttner

Hudson Institute


Eric Larson

Group Health Research Institute


Meghan Lawson

Cepheid, Inc.


Teresa Lee

Advanced Medical Technology Association


Greg Lennon

SNPedia


Debra Leonard

College of American Pathologists


Caryn Lerman

University of Pennsylvania


Leslie Levin

Medical Advisory Secretariat, Ministry of Health & Long-Term Care


Hallie Lewis

Cepheid, Inc.


Adriana Malheiro

National Center for Biotechnology Information


Elizabeth Mansfield

U.S. Food and Drug Administration


Robert McCormack

Veridex, LLC.


Stephen Michael

Policy Directions Inc.


James Mills

National Institutes of Health


C. Douglas Monroe

Kaiser Permanente


Amy Muhlberg

Life Technologies


Sharon Murphy

Institute of Medicine


Kathryn Phillips

University of California, San Francisco

Suggested Citation:"Appendix C: Registered Attendees." Institute of Medicine. 2011. Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13133.
×

Andre Pilon

American Association for Cancer Research


Margaret Piper

Blue Cross and Blue Shield Technology Evaluation Center


Irene Prabhu Das

National Cancer Institute


Jennifer Puck

University of California, San Francisco


Elizabeth Rach

Institute of Medicine


David Ransohoff

University of North Carolina at Chapel Hill


Lynnie Reid

Boston University School of Medicine


Wendy Rubinstein

NorthShore University Health System


Debi Sarkar

Maternal and Child Health Bureau Health Resources and Services Administration


Thomas Scarnecchia

Digital Aurora


Sheri Schully

National Cancer Institute


Fay Shamanski

College of American Pathologists


Richard Simon

National Cancer Institute


Scott Steele

University of Rochester


Robin Stombler

Auburn Health Strategies, LLC


Fang Sun

ECRI Institute


Weimin Tang

ShanghaiBio (US)


Cara Tenenbaum

Ovarian Cancer National Alliance


Sharon Terry

Genetic Alliance


Barry Thompson

American College of Medical Genetics


Martha Turner

American Nurses Association


Paul Vetter

PerkinElmer


Michael Watson

American College of Medical Genetics


Daniel J. Wattendorf

Department of the Air Force

Suggested Citation:"Appendix C: Registered Attendees." Institute of Medicine. 2011. Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13133.
×

Meredith Weaver

American College of Medical Genetics


Catherine Wicklund

National Society of Genetic Counselors


John Yeh

Beth Israel Deaconess Medical Center/Harvard Medical School

Suggested Citation:"Appendix C: Registered Attendees." Institute of Medicine. 2011. Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13133.
×

This page intentionally left blank.

Suggested Citation:"Appendix C: Registered Attendees." Institute of Medicine. 2011. Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13133.
×
Page 81
Suggested Citation:"Appendix C: Registered Attendees." Institute of Medicine. 2011. Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13133.
×
Page 82
Suggested Citation:"Appendix C: Registered Attendees." Institute of Medicine. 2011. Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13133.
×
Page 83
Suggested Citation:"Appendix C: Registered Attendees." Institute of Medicine. 2011. Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13133.
×
Page 84
Suggested Citation:"Appendix C: Registered Attendees." Institute of Medicine. 2011. Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13133.
×
Page 85
Suggested Citation:"Appendix C: Registered Attendees." Institute of Medicine. 2011. Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13133.
×
Page 86
Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary Get This Book
×
Buy Paperback | $29.00 Buy Ebook | $23.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Ten years after the sequencing of the human genome, scientists have developed genetic tests that can predict a person's response to certain drugs, estimate the risk of developing Alzheimer's disease, and make other predictions based on known links between genes and diseases. However, genetic tests have yet to become a routine part of medical care, in part because there is not enough evidence to show they help improve patients' health.

The Institute of Medicine (IOM) held a workshop to explore how researchers can gather better evidence more efficiently on the clinical utility of genetic tests. Generating Evidence for Genomic Diagnostic Test Development compares the evidence that is required for decisions regarding clearance, use, and reimbursement, to the evidence that is currently generated. The report also addresses innovative and efficient ways to generate high-quality evidence, as well as barriers to generating this evidence.

Generating Evidence for Genomic Diagnostic Test Development contains information that will be of great value to regulators and policymakers, payers, health-care providers, researchers, funders, and evidence-based review groups.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!